SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

Press Release

Published on 10/28/2021

2 min read

BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences:

  • Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11th at 2:40pm ET / 8:40pm CET
  • Piper Sandler 33rd Annual Healthcare Conference; Presentation available on demand beginning November 22nd at 10:00am ET / 4:00pm CET
  • Evercore ISI HealthCONx Conference; Fireside Chat on Tuesday, November 30th at 8:00am ET / 2:00pm CET

Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:
Eliza Bamonti
[email protected]

Investor Contact:
[email protected]

Sign Up To Our Newsletter

Enter your email address to join our mailing list and receive the latest news and updates from SOPHiA GENETICS. You can unsubscribe by using the link integrated with the communication at any time. By clicking to “sign up”, you agree that SOPHiA GENETICS will process your data in accordance with its Privacy Policy

pink dots icon

Recent Press Releases

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.